The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ibuprofen and Codeine Phosphate Tablets Market Research Report 2025
Synopsis
Profencodeine Tablets are compound preparations composed of ibuprofen and codeine phosphate. Ibuprofen is a non-steroidal anti-inflammatory drug, which has anti-inflammatory, antipyretic and analgesic effects. Its mechanism of action may be related to the inhibition of prostaglandin synthesis; It has analgesic effect, its analgesic effect is weaker than that of morphine, and it has antitussive effect. The combined use of the two can enhance the analgesic effect.
Global Ibuprofen and Codeine Phosphate Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ibuprofen and Codeine Phosphate Tablets market research.
Key manufacturers engaged in the Ibuprofen and Codeine Phosphate Tablets industry include Reckitt Benckiser, GlaxoSmithKline, Consumer Healthcare, Crookes Healthcare, SmithKline Beecham, Boots, FARMASIERRA, ABBOTT and CANTABRIA PHARMA, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Ibuprofen and Codeine Phosphate Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Ibuprofen and Codeine Phosphate Tablets market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Ibuprofen and Codeine Phosphate Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Reckitt Benckiser
GlaxoSmithKline
Consumer Healthcare
Crookes Healthcare
SmithKline Beecham
Boots
FARMASIERRA
ABBOTT
CANTABRIA PHARMA
FARMALIDER
Mundipharma
SSL
SINOPHARM
Segment Ibuprofen (g) /Codeine Phosphate (mg)
0.2/12.5
0.2/12.8
0.2/30
0.4/30
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ibuprofen and Codeine Phosphate Tablets report covers below items:
Chapter 1: Product Basic Information (Definition, profen (g) /Codeine Phosphate (mg) and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product profen (g) /Codeine Phosphate (mg) Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Profencodeine Tablets are compound preparations composed of ibuprofen and codeine phosphate. Ibuprofen is a non-steroidal anti-inflammatory drug, which has anti-inflammatory, antipyretic and analgesic effects. Its mechanism of action may be related to the inhibition of prostaglandin synthesis; It has analgesic effect, its analgesic effect is weaker than that of morphine, and it has antitussive effect. The combined use of the two can enhance the analgesic effect.
Global Ibuprofen and Codeine Phosphate Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ibuprofen and Codeine Phosphate Tablets market research.
Key manufacturers engaged in the Ibuprofen and Codeine Phosphate Tablets industry include Reckitt Benckiser, GlaxoSmithKline, Consumer Healthcare, Crookes Healthcare, SmithKline Beecham, Boots, FARMASIERRA, ABBOTT and CANTABRIA PHARMA, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Ibuprofen and Codeine Phosphate Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Ibuprofen and Codeine Phosphate Tablets market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Ibuprofen and Codeine Phosphate Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Reckitt Benckiser
GlaxoSmithKline
Consumer Healthcare
Crookes Healthcare
SmithKline Beecham
Boots
FARMASIERRA
ABBOTT
CANTABRIA PHARMA
FARMALIDER
Mundipharma
SSL
SINOPHARM
Segment Ibuprofen (g) /Codeine Phosphate (mg)
0.2/12.5
0.2/12.8
0.2/30
0.4/30
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ibuprofen and Codeine Phosphate Tablets report covers below items:
Chapter 1: Product Basic Information (Definition, profen (g) /Codeine Phosphate (mg) and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product profen (g) /Codeine Phosphate (mg) Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Ibuprofen and Codeine Phosphate Tablets Market Overview
1.1 Product Overview and Scope of Ibuprofen and Codeine Phosphate Tablets
1.2 Ibuprofen and Codeine Phosphate Tablets Segment Ibuprofen (g) /Codeine Phosphate (mg)
1.2.1 Global Ibuprofen and Codeine Phosphate Tablets Market Value Comparison Ibuprofen (g) /Codeine Phosphate (mg) (2023-2029)
1.2.2 0.2/12.5
1.2.3 0.2/12.8
1.2.4 0.2/30
1.2.5 0.4/30
1.2.6 Others
1.3 Ibuprofen and Codeine Phosphate Tablets Segment by Application
1.3.1 Global Ibuprofen and Codeine Phosphate Tablets Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Ibuprofen and Codeine Phosphate Tablets Market Size Estimates and Forecasts
1.4.1 Global Ibuprofen and Codeine Phosphate Tablets Revenue 2018-2029
1.4.2 Global Ibuprofen and Codeine Phosphate Tablets Sales 2018-2029
1.4.3 Global Ibuprofen and Codeine Phosphate Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Ibuprofen and Codeine Phosphate Tablets Market Competition by Manufacturers
2.1 Global Ibuprofen and Codeine Phosphate Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Ibuprofen and Codeine Phosphate Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Ibuprofen and Codeine Phosphate Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Ibuprofen and Codeine Phosphate Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Ibuprofen and Codeine Phosphate Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ibuprofen and Codeine Phosphate Tablets, Product Type & Application
2.7 Ibuprofen and Codeine Phosphate Tablets Market Competitive Situation and Trends
2.7.1 Ibuprofen and Codeine Phosphate Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ibuprofen and Codeine Phosphate Tablets Players Market Share by Revenue
2.7.3 Global Ibuprofen and Codeine Phosphate Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ibuprofen and Codeine Phosphate Tablets Retrospective Market Scenario by Region
3.1 Global Ibuprofen and Codeine Phosphate Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Ibuprofen and Codeine Phosphate Tablets Global Ibuprofen and Codeine Phosphate Tablets Sales by Region: 2018-2029
3.2.1 Global Ibuprofen and Codeine Phosphate Tablets Sales by Region: 2018-2023
3.2.2 Global Ibuprofen and Codeine Phosphate Tablets Sales by Region: 2024-2029
3.3 Global Ibuprofen and Codeine Phosphate Tablets Global Ibuprofen and Codeine Phosphate Tablets Revenue by Region: 2018-2029
3.3.1 Global Ibuprofen and Codeine Phosphate Tablets Revenue by Region: 2018-2023
3.3.2 Global Ibuprofen and Codeine Phosphate Tablets Revenue by Region: 2024-2029
3.4 North America Ibuprofen and Codeine Phosphate Tablets Market Facts & Figures by Country
3.4.1 North America Ibuprofen and Codeine Phosphate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Ibuprofen and Codeine Phosphate Tablets Sales by Country (2018-2029)
3.4.3 North America Ibuprofen and Codeine Phosphate Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ibuprofen and Codeine Phosphate Tablets Market Facts & Figures by Country
3.5.1 Europe Ibuprofen and Codeine Phosphate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Ibuprofen and Codeine Phosphate Tablets Sales by Country (2018-2029)
3.5.3 Europe Ibuprofen and Codeine Phosphate Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ibuprofen and Codeine Phosphate Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Ibuprofen and Codeine Phosphate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Ibuprofen and Codeine Phosphate Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Ibuprofen and Codeine Phosphate Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ibuprofen and Codeine Phosphate Tablets Market Facts & Figures by Country
3.7.1 Latin America Ibuprofen and Codeine Phosphate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Ibuprofen and Codeine Phosphate Tablets Sales by Country (2018-2029)
3.7.3 Latin America Ibuprofen and Codeine Phosphate Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ibuprofen and Codeine Phosphate Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Ibuprofen and Codeine Phosphate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Ibuprofen and Codeine Phosphate Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Ibuprofen and Codeine Phosphate Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment Ibuprofen (g) /Codeine Phosphate (mg)
4.1 Global Ibuprofen and Codeine Phosphate Tablets Sales Ibuprofen (g) /Codeine Phosphate (mg) (2018-2029)
4.1.1 Global Ibuprofen and Codeine Phosphate Tablets Sales Ibuprofen (g) /Codeine Phosphate (mg) (2018-2023)
4.1.2 Global Ibuprofen and Codeine Phosphate Tablets Sales Ibuprofen (g) /Codeine Phosphate (mg) (2024-2029)
4.1.3 Global Ibuprofen and Codeine Phosphate Tablets Sales Market Share Ibuprofen (g) /Codeine Phosphate (mg) (2018-2029)
4.2 Global Ibuprofen and Codeine Phosphate Tablets Revenue Ibuprofen (g) /Codeine Phosphate (mg) (2018-2029)
4.2.1 Global Ibuprofen and Codeine Phosphate Tablets Revenue Ibuprofen (g) /Codeine Phosphate (mg) (2018-2023)
4.2.2 Global Ibuprofen and Codeine Phosphate Tablets Revenue Ibuprofen (g) /Codeine Phosphate (mg) (2024-2029)
4.2.3 Global Ibuprofen and Codeine Phosphate Tablets Revenue Market Share Ibuprofen (g) /Codeine Phosphate (mg) (2018-2029)
4.3 Global Ibuprofen and Codeine Phosphate Tablets Price Ibuprofen (g) /Codeine Phosphate (mg) (2018-2029)
5 Segment by Application
5.1 Global Ibuprofen and Codeine Phosphate Tablets Sales by Application (2018-2029)
5.1.1 Global Ibuprofen and Codeine Phosphate Tablets Sales by Application (2018-2023)
5.1.2 Global Ibuprofen and Codeine Phosphate Tablets Sales by Application (2024-2029)
5.1.3 Global Ibuprofen and Codeine Phosphate Tablets Sales Market Share by Application (2018-2029)
5.2 Global Ibuprofen and Codeine Phosphate Tablets Revenue by Application (2018-2029)
5.2.1 Global Ibuprofen and Codeine Phosphate Tablets Revenue by Application (2018-2023)
5.2.2 Global Ibuprofen and Codeine Phosphate Tablets Revenue by Application (2024-2029)
5.2.3 Global Ibuprofen and Codeine Phosphate Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Ibuprofen and Codeine Phosphate Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Reckitt Benckiser
6.1.1 Reckitt Benckiser Corporation Information
6.1.2 Reckitt Benckiser Description and Business Overview
6.1.3 Reckitt Benckiser Ibuprofen and Codeine Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Reckitt Benckiser Ibuprofen and Codeine Phosphate Tablets Product Portfolio
6.1.5 Reckitt Benckiser Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Ibuprofen and Codeine Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GlaxoSmithKline Ibuprofen and Codeine Phosphate Tablets Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Consumer Healthcare
6.3.1 Consumer Healthcare Corporation Information
6.3.2 Consumer Healthcare Description and Business Overview
6.3.3 Consumer Healthcare Ibuprofen and Codeine Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Consumer Healthcare Ibuprofen and Codeine Phosphate Tablets Product Portfolio
6.3.5 Consumer Healthcare Recent Developments/Updates
6.4 Crookes Healthcare
6.4.1 Crookes Healthcare Corporation Information
6.4.2 Crookes Healthcare Description and Business Overview
6.4.3 Crookes Healthcare Ibuprofen and Codeine Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Crookes Healthcare Ibuprofen and Codeine Phosphate Tablets Product Portfolio
6.4.5 Crookes Healthcare Recent Developments/Updates
6.5 SmithKline Beecham
6.5.1 SmithKline Beecham Corporation Information
6.5.2 SmithKline Beecham Description and Business Overview
6.5.3 SmithKline Beecham Ibuprofen and Codeine Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 SmithKline Beecham Ibuprofen and Codeine Phosphate Tablets Product Portfolio
6.5.5 SmithKline Beecham Recent Developments/Updates
6.6 Boots
6.6.1 Boots Corporation Information
6.6.2 Boots Description and Business Overview
6.6.3 Boots Ibuprofen and Codeine Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Boots Ibuprofen and Codeine Phosphate Tablets Product Portfolio
6.6.5 Boots Recent Developments/Updates
6.7 FARMASIERRA
6.6.1 FARMASIERRA Corporation Information
6.6.2 FARMASIERRA Description and Business Overview
6.6.3 FARMASIERRA Ibuprofen and Codeine Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 FARMASIERRA Ibuprofen and Codeine Phosphate Tablets Product Portfolio
6.7.5 FARMASIERRA Recent Developments/Updates
6.8 ABBOTT
6.8.1 ABBOTT Corporation Information
6.8.2 ABBOTT Description and Business Overview
6.8.3 ABBOTT Ibuprofen and Codeine Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 ABBOTT Ibuprofen and Codeine Phosphate Tablets Product Portfolio
6.8.5 ABBOTT Recent Developments/Updates
6.9 CANTABRIA PHARMA
6.9.1 CANTABRIA PHARMA Corporation Information
6.9.2 CANTABRIA PHARMA Description and Business Overview
6.9.3 CANTABRIA PHARMA Ibuprofen and Codeine Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 CANTABRIA PHARMA Ibuprofen and Codeine Phosphate Tablets Product Portfolio
6.9.5 CANTABRIA PHARMA Recent Developments/Updates
6.10 FARMALIDER
6.10.1 FARMALIDER Corporation Information
6.10.2 FARMALIDER Description and Business Overview
6.10.3 FARMALIDER Ibuprofen and Codeine Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 FARMALIDER Ibuprofen and Codeine Phosphate Tablets Product Portfolio
6.10.5 FARMALIDER Recent Developments/Updates
6.11 Mundipharma
6.11.1 Mundipharma Corporation Information
6.11.2 Mundipharma Ibuprofen and Codeine Phosphate Tablets Description and Business Overview
6.11.3 Mundipharma Ibuprofen and Codeine Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Mundipharma Ibuprofen and Codeine Phosphate Tablets Product Portfolio
6.11.5 Mundipharma Recent Developments/Updates
6.12 SSL
6.12.1 SSL Corporation Information
6.12.2 SSL Ibuprofen and Codeine Phosphate Tablets Description and Business Overview
6.12.3 SSL Ibuprofen and Codeine Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 SSL Ibuprofen and Codeine Phosphate Tablets Product Portfolio
6.12.5 SSL Recent Developments/Updates
6.13 SINOPHARM
6.13.1 SINOPHARM Corporation Information
6.13.2 SINOPHARM Ibuprofen and Codeine Phosphate Tablets Description and Business Overview
6.13.3 SINOPHARM Ibuprofen and Codeine Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 SINOPHARM Ibuprofen and Codeine Phosphate Tablets Product Portfolio
6.13.5 SINOPHARM Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ibuprofen and Codeine Phosphate Tablets Industry Chain Analysis
7.2 Ibuprofen and Codeine Phosphate Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ibuprofen and Codeine Phosphate Tablets Production Mode & Process
7.4 Ibuprofen and Codeine Phosphate Tablets Sales and Marketing
7.4.1 Ibuprofen and Codeine Phosphate Tablets Sales Channels
7.4.2 Ibuprofen and Codeine Phosphate Tablets Distributors
7.5 Ibuprofen and Codeine Phosphate Tablets Customers
8 Ibuprofen and Codeine Phosphate Tablets Market Dynamics
8.1 Ibuprofen and Codeine Phosphate Tablets Industry Trends
8.2 Ibuprofen and Codeine Phosphate Tablets Market Drivers
8.3 Ibuprofen and Codeine Phosphate Tablets Market Challenges
8.4 Ibuprofen and Codeine Phosphate Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
